AVE: Interim analysis of a major CBD insomnia trial could unlock global OTC and licensing opportunities – TradingView AVE: Interim analysis of a major CBD insomnia trial could unlock global OTC and licensing opportunities TradingView Brought to you by Google News. Read the rest of the article here Facebook Twitter Pinterest